Company Description
Stryker Corporation operates as a medical technology company in the United States and internationally.
It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products.
The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications.
The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries.
Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
| Country | United States |
| Founded | 1941 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 56,000 |
| CEO | Kevin Lobo |
Contact Details
Address: 1941 Stryker Way Portage, Michigan 49002 United States | |
| Phone | (269) 385-2600 |
| Website | stryker.com |
Stock Details
| Ticker Symbol | SYK |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000310764 |
| CUSIP Number | 863667101 |
| ISIN Number | US8636671013 |
| Employer ID | 38-1239739 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Kevin A. Lobo | Chairman and Chief Executive Officer |
| Spencer S. Stiles | President and Chief Operating Officer |
| Viju S. Menon | Group President of Global Quality and Operations |
| J. Andrew Pierce | Group President of MedSurg and Neurotechnology |
| Preston W. Wells | Vice President and Chief Financial Officer |
| William E. Berry Jr. | Vice President and Chief Accounting Officer |
| Robert C. Cohen | Chief Technology Officer and Vice President of Global Research & Development - Joint Replacement |
| Alan Douville | Vice President, Chief Information Officer and Chief Information Security Officer |
| Jason Beach | Vice President of Finance and Investor Relations |
| Robert S. Fletcher | Vice President and Chief Legal Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 12, 2026 | 8-K | Current Report |
| Mar 11, 2026 | 8-K | Current Report |
| Feb 11, 2026 | SCHEDULE 13G/A | Filing |
| Feb 11, 2026 | 10-K | Annual Report |
| Feb 2, 2026 | 144 | Filing |
| Jan 29, 2026 | 8-K | Current Report |
| Dec 4, 2025 | 8-K | Current Report |
| Nov 20, 2025 | 144 | Filing |
| Nov 14, 2025 | 144 | Filing |
| Nov 5, 2025 | 144 | Filing |